HR 4981 · 114th Congress 2015–2017, ended

Opioid Use Disorder Treatment Expansion and Modernization Act

Latest action · May 12, 2016 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 18, 2016
  2. Passed HouseMay 11, 2016
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Opioid Use Disorder Treatment Expansion and Modernization Act

(Sec. 3) This bill amends the Controlled Substances Act to revise the requirements for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.

Currently, a practitioner must notify the Department of Health and Human Services (HHS) and certify that he or she is a qualifying physician (i.e., a state-licensed physician with certain expertise), has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. The patient limit is how many patients the practitioner can treat under the office-based treatment program at one time.

This legislation expands qualifying practitioners to include nurse practitioners and physician assistants who are licensed in a state, have expertise (such as relevant training or expertise), and prescribe medications for opioid use disorder in collaboration with or under the supervision of a qualifying physician if state law requires physician oversight of prescribing authority.

Additionally, it requires a qualifying practitioner to also certify that he or she will comply with reporting requirements and has the capacity to provide directly or by referral, or in another manner prescribed by HHS, all drugs approved by the Food and Drug Administration to treat opioid use disorder.

HHS may issue regulations to change the maximum patient limit for a qualifying practitioner. If HHS increases the limit, then a qualifying practitioner must additionally certify that he or she will obtain written consent from each patient regarding available treatment options.

HHS must update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings.

HHS may recommend revoking or suspending the registration of a practitioner who fails to comply with the requirements of this Act.

(Sec. 4) The bill expresses the sense of Congress that HHS should consider raising from 100 to 250 the maximum patient limit for a qualifying physician.

(Sec. 5) It amends the Controlled Substances Act to allow a pharmacist to partially fill a prescription for a schedule II controlled substance (such as a prescription opioid painkiller) if: (1) it is not prohibited by state law, (2) it is prescribed in accordance with existing laws and regulations, (3) it is requested by the patient or prescribing practitioner, and (4) the total quantity dispensed in partial fillings does not exceed the total quantity prescribed.

Additionally, a pharmacist may partially fill a prescription for a schedule II controlled substance in other circumstances in accordance with existing Drug Enforcement Administration (DEA) regulations. (Current DEA regulations permit partial fills when a pharmacist cannot supply a full quantity, a patient resides in a long-term care facility, or a patient is terminally ill.)

The remaining of a partially filled prescription may be filled within 30 days or, in the case of an emergency situation, within 72 hours.

Cosponsors 2

Members who signed on, in the order they did. Signatures ran from Apr 18, 2016 to Apr 28, 2016; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-NYPaul TonkoOriginalApr 18, 2016
R-INTodd RokitaApr 28, 2016

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 18, 2016Markup Apr 27, 2016Reported May 11, 2016
Health Subcommittee
Referred Apr 22, 2016
HouseJudiciary Committee
Referred Apr 18, 2016Discharged May 11, 2016
Crime and Federal Government Surveillance Subcommittee
Referred Apr 20, 2016
SenateHealth, Education, Labor, and Pensions Committee
Referred May 12, 2016

Actions 17

Everything that happened, newest first.

  1. May 12, 2016Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. May 11, 2016Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
  3. May 11, 2016Considered under suspension of the rules. (consideration: CR H2276-2280)
  4. May 11, 2016DEBATE - The House proceeded with forty minutes of debate on H.R. 4981.
  5. May 11, 2016Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2276-2277)
  6. May 11, 2016Motion to reconsider laid on the table Agreed to without objection.
  7. May 10, 2016Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-561, Part I.
  8. May 10, 2016Committee on the Judiciary discharged.
  9. May 10, 2016Placed on the Union Calendar, Calendar No. 435.
  10. Apr 27, 2016Committee Consideration and Mark-up Session Held.
  11. Apr 27, 2016Ordered to be Reported (Amended) by Voice Vote.
  12. Apr 26, 2016Committee Consideration and Mark-up Session Held.
  13. Apr 25, 2016Committee Consideration and Mark-up Session Held.
  14. Apr 22, 2016Referred to the Subcommittee on Health.
  15. Apr 20, 2016Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  16. Apr 18, 2016Introduced in House
  17. Apr 18, 2016Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H2225, H2276–H2280Text printed H2276Brett Guthrie R-KY, Brian Higgins D-NY, Earl L. "Buddy" Carter R-GA, Gene Green D-TX, Larry Bucshon R-IN, Paul Tonko D-NY, Sheila Jackson Lee D-TXMay 11, 2016

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimates 2

  1. Jun 29, 2016H.R. 4981, Opioid Use Disorder Treatment Expansion and Modernization ActRevised cost estimate for H.R. 4981, as passed by the House of Representatives on May 11, 2016
  2. May 31, 2016H.R. 4981, Opioid Use Disorder Treatment Expansion and Modernization ActAs passed by the House of Representatives on May 11, 2016

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 3 of the United States Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 162, no. 59, April 18, 2016, page H1802.

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 524Comprehensive Addiction and Recovery Act of 2016Related billJul 22, 2016
HR 4599Reducing Unused Medications Act of 2016Related billMay 12, 2016
HR 5189Opioid Abuse Crisis Act of 2016Related billJun 7, 2016

Titles 4

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Controlled Substances Act to improve access to opioid use disorder treatment.
Short Titles as Introduced
Opioid Use Disorder Treatment Expansion and Modernization Act
Short Titles as Reported to House
Opioid Use Disorder Treatment Expansion and Modernization Act
Short Titles as Passed House
Opioid Use Disorder Treatment Expansion and Modernization Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 4

Each version as it was printed, newest first.

  1. May 12, 2016Referred in Senate
  2. May 11, 2016Engrossed in House
  3. May 10, 2016Reported in House
  4. Apr 18, 2016Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.